What the problem is
People with type 1 diabetes don’t make insulin because their immune system destroys the cells in the pancreas that produce it. The only way to stay alive is by taking insulin every day. Scientists have long dreamed of transplanting insulin-producing cells into these patients, but the immune system usually attacks and kills transplanted cells unless the patient takes powerful drugs to suppress immunity. Those drugs can cause serious side effects. What the researchers tried
In this new study (published in The New England Journal of Medicine in September 2025), doctors in Sweden and Norway tested a different approach:
1. They took insulin-producing cells (islet cells) from a donor pancreas.
2. They gene-edited the cells using CRISPR so they would not be recognized and attacked by the immune system:
- They removed certain 'ID tags' (HLA proteins) that trigger rejection.
- They added extra 'don’t eat me' signals (CD47) to make the cells invisible to immune attack.
3. They transplanted nearly 80 million of these edited cells into the forearm muscle of a 42-year-old man who had lived with type 1 diabetes for 37 years.
4. Importantly, he received no immunosuppressive drugs at all.
What happened
- For at least 12 weeks after the transplant, the patient’s body showed no immune reaction against the edited cells.
- The transplanted cells made insulin in response to food, which doctors confirmed with blood tests.
- The patient’s blood sugar control improved, and there were no serious side effects.
Why it matters
This is the first human case showing that gene-edited donor insulin-producing cells can survive and function without immune-suppressing drugs. It offers a proof of concept that, one day, type 1 diabetes might be treated with a cell transplant that acts like a natural cure—without the risks of lifelong medication.
Caveats
- This was just one patient, followed for only 3 months.
- More studies, with higher doses and longer monitoring, are needed before this becomes a standard therapy.
In short
A man with type 1 diabetes received CRISPR-edited donor insulin cells in his arm. They worked, made insulin, and survived without rejection—all without immune-suppressing drugs. It’s an early but groundbreaking step toward a real biological cure for type 1 diabetes.
Reference: Carlsson P O, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S. "Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression." The New England Journal of Medicine. 2025 Sep 4;393(9):887-894. DOI: 10.1056/NEJMoa2503822.